Cover Image
Read Now

Acetylsalicylic acid for venous thromboembolism prophylaxis comparative clinical effectiveness and guidelines

The purpose of this report is to examine the comparative clinical effectiveness of acetylsalicylic acid versus low-molecular-weight heparin or factor Xa inhibitors, and evidence-based guidelines regarding the use of acetylsalicylic acid or low-molecular-weight heparin, for venous thromboembolism pro...

Full description

Bibliographic Details
Main Authors: Poitras, Veronica, Adcock, Lorna (Author)
Corporate Author: Canadian Agency for Drugs and Technologies in Health
Format: eBook
Language:English
Published: Ottawa (ON) CADTH November 14, 2017, 2017
Series:CADTH rapid response report: summary with critical appraisal
Subjects:
Factor Xa Inhibitors / Therapeutic Use
Arthroplasty / Adverse Effects
Aspirin / Therapeutic Use
Treatment Outcome
Heparin, Low-molecular-weight / Therapeutic Use
Venous Thromboembolism / Prevention & Control
Online Access:
Collection: National Center for Biotechnology Information - Collection details see MPG.ReNa
Description
Summary:The purpose of this report is to examine the comparative clinical effectiveness of acetylsalicylic acid versus low-molecular-weight heparin or factor Xa inhibitors, and evidence-based guidelines regarding the use of acetylsalicylic acid or low-molecular-weight heparin, for venous thromboembolism prophylaxis in patients undergoing total hip or knee replacement surgeries
Physical Description:1 PDF file (41 pages) illustration

Similar Items